Tema Oncology ETF
Limited financial coverage for CANC.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
About the company
The Tema Oncology ETF (CANC) is designed to strategically invest in companies well-positioned to capitalize on significant advancements within cancer-focused biotechnology and the broader healthcare sector.
- IPO
- 2023
- HQ
- New York, NY, US
Price Chart
- Market Cap
- $132.70M
- Div Yield
- 0.05%
- 52W High
- $41.99
- 52W Low
- $24.77
- 50D MA
- $37.94
- 200D MA
- $35.21
- Beta
- 0.70
- Avg Volume
- 31.18K
Get TickerSpark's AI analysis on CANC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our CANC coverage
Recent articles, reports, and earnings notes.
No research on CANC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CANC report →Similar companies
Peers in the same neighborhood.